Assessment of T and B cell responses to 3 doses of the Pfizer BioNTech SARS CoV2 mRNA vaccine in patients with kidney transplant who were on Belatacept
Latest Information Update: 03 Aug 2022
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 03 Aug 2022 New trial record
- 08 Jun 2022 Results presented at the 2022 American Transplant Congress